Position
Renaissance Technologies in Collegium Pharmaceutical, Inc
Back to the book · All holders of COLL
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $4.28M$33.07 → $36.20
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 1.62M | $74.9M | — | — | — | 0.1% |
| Q1 2026 | 1.47M | $48.6M | $33.07 | −$19.4M | −$6.85M | 0.1% |
| Q2 2026 | 1.37M | $49.5M | $36.20 | $4.28M | −$3.4M | 0.1% |